A Phase 1 Study of [225Ac]-FPI-1434 Injection
Fusion Pharmaceuticals Inc.
Fusion Pharmaceuticals Inc.
Pfizer
Tempus AI
Incyte Corporation
Actym Therapeutics, Inc.
Bolt Biotherapeutics, Inc.
University of Virginia
Lyell Immunopharma, Inc.
Lyell Immunopharma, Inc.
Dana-Farber Cancer Institute
Pfizer
NextCure, Inc.
Elevation Oncology
Valerio Therapeutics
Deciphera Pharmaceuticals, LLC
Aminex Therapeutics, Inc.
Five Prime Therapeutics, Inc.
Tango Therapeutics, Inc.
NantCell, Inc.
Haihe Biopharma Co., Ltd.
CytomX Therapeutics
Fusion Pharmaceuticals Inc.
Leap Therapeutics, Inc.
Pfizer
pharmaand GmbH
Fate Therapeutics
Tesaro, Inc.
National Institutes of Health Clinical Center (CC)
MacroGenics
University of Pennsylvania
Novartis
Dr. Horst Schmidt Klinik GmbH
Syros Pharmaceuticals
Seagen Inc.
Cambridge University Hospitals NHS Foundation Trust
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Vanderbilt-Ingram Cancer Center
City of Hope Medical Center
National Institutes of Health Clinical Center (CC)
CureOne
Pfizer
Novartis
Vanderbilt-Ingram Cancer Center
University Health Network, Toronto
Pfizer
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
OHSU Knight Cancer Institute
OHSU Knight Cancer Institute